Validation experiments confirmed the excellent performance and independent predictive effect of this ESCC-PS, and the incremental value for the expression of PD-L1 for outcome prediction of PD-1 inhibitors. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.